Reference : Graph neural networks for investigating complex diseases: A case study on Parkinson's...
Scientific congresses, symposiums and conference proceedings : Poster
Life sciences : Biochemistry, biophysics & molecular biology
Life sciences : Multidisciplinary, general & others
Engineering, computing & technology : Computer science
Engineering, computing & technology : Multidisciplinary, general & others
Computational Sciences; Systems Biomedicine
http://hdl.handle.net/10993/56048
Graph neural networks for investigating complex diseases: A case study on Parkinson's Disease
English
Gómez de Lope, Elisa mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science >]
Viñas Torné, Ramón mailto []
Liò, Pietro mailto []
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science >]
25-Jul-2023
Yes
International
31st Annual Intelligent Systems For Molecular Biology and the 22nd Annual European Conference on Computational Biology
from 23-07-2023 to 27-07-2023
International Society of Computational Biology
Lyon
France
[en] Graph representation learning ; omics ; Parkinson's Disease ; machine learning ; graphs ; networks
[en] Omics data analysis is a critical component in the study of complex diseases, but the high dimension and heterogeneity of the data often pose challenges that are difficult to address by classical statistical and machine learning methods. Recently, structured data analyses using graph neural networks (GNNs) have emerged as a promising complementary approach, particularly for investigating the relational information between samples. However, it is still unclear which strategies for designing and optimizing GNNs are most effective when working with real-world data from complex disorders, such as Parkinson's disease (PD).
Our study addresses this gap by examining the application of various GNN models, including Graph
Convolutional Network, ChebyNet, and Graph Attention Network, to identify and interpret
discriminative patterns between PD patients and controls using omics data. The developed pipeline
integrates Lasso penalty-based feature selection, similarity graph construction, and final modeling for sample classification. Through an end-to-end model building and evaluation process, we assess the practical utility of the pipeline on independent PD omics datasets.
Overall, our analyses highlight some of the benefits and challenges of using graph structure data for machine learning analysis of disease-related omics data and provide directions for further research.
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Fonds National de la Recherche - FnR
R-AGR-0621 > Dons Alzheimer Projekt (Dr. Glaab) > 26/10/2015 - 19/01/2048 > SCHNEIDER Reinhard
Researchers ; Professionals ; Students ; General public
http://hdl.handle.net/10993/56048
FnR ; FNR14599012 > Enrico Glaab > DIGIPD > Validating Digital Biomarkers For Better Personalized Treatment Of Parkinson’S Disease > 01/05/2021 > 30/04/2024 > 2020

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
ISMBECCB2023_1251_GomezdeLope_poster.pdfPublisher postprint12.93 MBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.